The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication ... acute pain is more sudden – often caused by surgery or injury – and is ...

The Food and Drug Administration this week approved a new type of painkiller that doesn’t carry the risk of addiction or overdose associated with opioid medications ... pain often caused by ...